Weiss Multi-Strategy Advisers’s Ironwood Pharmaceuticals IRWD Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-29,850	Closed	-$308K	–	822
2014 Q1	$308K	Buy	+29,850	New	+$336K	0.01%	806
2013 Q3	–	Sell	-23,880	Closed	-$199K	–	949
2013 Q2	$199K	Buy	+23,880	New	+$289K	0.01%	713

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Weiss Multi-Strategy Advisers's IRWD Position: Q1 2018 in Review

Weiss Multi-Strategy Advisers sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2018, closing a stake of 71,640 shares — an estimated $899K sold.

Weiss Multi-Strategy Advisers first reported a position in IRWD in Q2 2013 and held it in 19 quarters. The position peaked at $2.38M in Q2 2014. 149 funds tracked by Wall St. Rank hold IRWD as of Q1 2018.

Weiss Multi-Strategy Advisers reported no remaining Ironwood Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 71,640 Ironwood Pharmaceuticals shares in Q1 2018, an estimated $899K.
Weiss Multi-Strategy Advisers first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 19 quarters.
Weiss Multi-Strategy Advisers's Ironwood Pharmaceuticals position peaked at $2.38M in Q2 2014.
149 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2018.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2018, filed 15 May 2018.